Sma Equities

Biogen Reports Positive Outcomes from Higher-Dose Nusinersen Trial in SMA Treatment Sep 5, 2024

Sylvamo Corporation SLVM Rises Above the 20-Day Moving Average: What This Means for Investors Jun 7, 2024

Leidos LDOS Surges Past the 20-Day Moving Average: A Positive Indicator for Investors May 3, 2024